MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-18-0005844
JMB Pharmaceuticals Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹25.18 Cr
▲ 22% YoY
Net profit · FY 2024
₹1.27 Cr
Net margin 5%
EBITDA · FY 2024
₹2.04 Cr
EBITDA margin 8.1%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹85 Lakh
Issued & subscribed
Open charges
₹4.39 Cr
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
2
As per MCA filings
About JMB Pharmaceuticals Private Limited
Data last updated:
JMB Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U32503MH2014PTC256657. Its GSTIN is 27AADCJ3908N1Z8 (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹85 Lakh. It is led by directors John Benno Marina and Benno John Nangani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 17 Meghal Industrial Estate Devidayal Road Mulund (W), Mumbai, Maharashtra, India – 400080.
As per the financials filed for FY 2024, the company reported a revenue of ₹25.18 Cr, a growth of 22% compared to the previous year. For the same year it recorded a net profit of ₹1.27 Cr (net margin 5%) and EBITDA of ₹2.04 Cr (EBITDA margin 8.1%). Revenue has grown at a compounded annual rate (CAGR) of 22% over three years and 13% over five years.
The company is associated with 1 brand: JMB Pharmaceuticals. As per MCA filings, the company has open charges of ₹4.39 Cr on record.
JMB Pharmaceuticals Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-18-0005844). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jmbpharma.com.
Company Details of JMB Pharmaceuticals Private Limited
CIN U32503MH2014PTC256657
Registration Number 256657
Incorporation Date 28 July 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-18-0005844
CIN History of JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals has one previous CIN (Corporate Identification Number): U24233MH2014PTC256657. The current CIN is U32503MH2014PTC256657, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U32503MH2014PTC256657 | Current |
| U24233MH2014PTC256657 | Previous |
Recognitions & Rankings of JMB Pharmaceuticals
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressG – 17 Meghal Industrial Estate Devidayal Road Mulund (W), Mumbai, Maharashtra, India – 400080
- IndustryHealthcare, Medical & Laboratory Equipment, Medical Consumables & Supplies
Comprehensive company report
JMB Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals operates one associated brand: JMB Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical formulations and veterinary products manufacturing in Mumbai. | jmbpharma.com |
Business Activity of JMB Pharmaceuticals Private Limited
The main business activity of JMB Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of JMB Pharmaceuticals Private Limited FY 2025 filings available
JMB Pharmaceuticals Private Limited reported revenue of ₹25.18 Cr (up 22% YoY) for FY 2024.
Revenue · FY 2024
₹25.18 Cr ▲ 22%
Net profit · FY 2024
₹1.27 Cr margin 5%
EBITDA · FY 2024
₹2.04 Cr margin 8.1%
Compounded Annual Growth Rate (CAGR) of JMB Pharmaceuticals Private Limited
Revenue CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 22%
5 years · compounded
▲ 13%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▲ 14%
5 years · compounded
▲ 6%
Revenue has grown at a compounded annual rate (CAGR) of 13% over five years, including 22% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of JMB Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.04 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.27 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of JMB Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of JMB Pharmaceuticals are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| John Benno Marina | Director | 30 Nov 2021 | 4 Years 10 Months | Current |
| Benno John Nangani | Director | 28 Jul 2014 | 12 Years 2 Months | Current |
Peer Comparison of JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synchem Laboratories Private Limited | ₹25.3 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Vadodara, Gujarat, India |
| Advanced Lifesciences Private Limited | ₹25.27 Cr (FY 2024) | •••• | •••• | -2.0% | •••• | New Delhi, Delhi, India |
| Medgel Private Limited | ₹25.23 Cr (FY 2025) | •••• | •••• | 23.0% | •••• | Indore, Madhya Pradesh, India |
| Tanmed Pharma India Private Limited | ₹25.2 Cr (FY 2024) | •••• | •••• | -7.0% | •••• | Chennai, Tamil Nadu, India |
| Ornate Labs Private Limited | ₹25.2 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Muzaffarpur, Bihar, India |
| JMB Pharmaceuticals Private Limited this company | ₹25.18 Cr (FY 2024) | •••• | •••• | 22.0% | •••• | Mumbai, Maharashtra, India |
| Piramal Phytocare Limited | ₹25.17 Cr (FY 2019) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Fitwel Pharmaceuticals Private Limited | ₹25.09 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Mumbai, Maharashtra, India |
| Origin Formulations Private Limited | ₹25.07 Cr (FY 2018) | •••• | •••• | -42.0% | •••• | Ahmedabad, Gujarat, India |
| Unistar Biotech Limited | ₹25.06 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Ahmedabad, Gujarat, India |
| Genuine Biosystem Private Limited | ₹25.06 Cr (FY 2024) | •••• | •••• | 26.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below JMB Pharmaceuticals by revenue in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals Private Limited is audited by V. VAIDYANATHAN & CO. for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V. VAIDYANATHAN & CO. | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of JMB Pharmaceuticals Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of JMB Pharmaceuticals Private Limited
Open charges
₹4.39 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2025 | Hdfc Bank Limited | ₹38 Lakh | Open |
| 01 Jun 2020 | Others | ₹20 Lakh | Open |
| 01 Jun 2020 | Others | ₹21 Lakh | Open |
| 16 May 2016 | Others | ₹10 Lakh | Open |
| 30 Jun 2015 | Others | ₹3.5 Cr | Open |
Total charge records: 5 View all charges
Employees and EPFO Compliance at JMB Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to JMB Pharmaceuticals.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Benny John Nangani ceased to be Director on 24 Jan 2022.
AGM
Jmb Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.38 Cr with Charge ID 101095547 was registered on 05 Apr 2025.
Filing
Jmb Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 3.50 Cr registered on 30 Jun 2015 with Charge ID 10581914 was modified on 17 Feb 2024.
Ceased
Benny John Nangani ceased to be Director.
Appointed
John Benno Marina was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.20 Cr with Charge ID 100340063 was registered on 01 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.21 Cr with Charge ID 100340064 was registered on 01 Jun 2020.
Charges
A charge with Others amounted to Rs. 0.10 Cr with Charge ID 100035643 was registered on 16 May 2016.
Charges
A charge with Others amounted to Rs. 3.50 Cr with Charge ID 10581914 was registered on 30 Jun 2015.
Appointed
Benno John Nangani was appointed as Director.
Incorporation
28 Jul 2014
Jmb Pharmaceuticals Private Limited was registered on 28 Jul 2014 with Roc Mumbai & aged 12 years 2 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for JMB Pharmaceuticals Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by JMB Pharmaceuticals Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of JMB Pharmaceuticals Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCJ3908N1Z8 | Maharashtra | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of JMB Pharmaceuticals Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about JMB Pharmaceuticals Private Limited
JMB Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 July 2014 (12+ years old) and is registered under CIN U32503MH2014PTC256657.
JMB Pharmaceuticals reported revenue of ₹25.18 Cr for FY 2024 (up 22% YoY).
JMB Pharmaceuticals has 2 current directors:
- John Benno Marina - Director
- Benno John Nangani - Director
JMB Pharmaceuticals reported a net profit of ₹1.27 Cr (net margin 5%) and EBITDA of ₹2.04 Cr (EBITDA margin 8.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of JMB Pharmaceuticals is 22% over three years and 13% over five years. In the latest year (FY 2024) revenue rose 22%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of JMB Pharmaceuticals is 27AADCJ3908N1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of JMB Pharmaceuticals is U32503MH2014PTC256657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JMB Pharmaceuticals was incorporated on 28 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of JMB Pharmaceuticals by revenue are Synchem Laboratories Private Limited, Advanced Lifesciences Private Limited, Medgel Private Limited, Tanmed Pharma India Private Limited, Ornate Labs Private Limited and 5 more, all in the Healthcare industry (Formulations, Medical Consumables, Medical and Laboratory Equipment).
Benny John Nangani ceased to be Director on 24 Jan 2022. John Benno Marina was appointed as Director on 30 Nov 2021. Benno John Nangani was appointed as Director on 28 Jul 2014.
Yes, JMB Pharmaceuticals is registered as an MSME under Udyam registration (number: UDYAM-MH-18-0005844).